|Bid||2.6500 x 800|
|Ask||3.3000 x 1800|
|Day's Range||2.6700 - 2.7266|
|52 Week Range||1.1800 - 4.2100|
|Beta (3Y Monthly)||0.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 13, 2017 - Mar 17, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
CARLSBAD, Calif., April 18, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to.
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the promotion of David Sponsel into the role of Executive Vice President, Sales. The Company also announced the closing of its expanded $30 million secured financing facility with Squadron Medical Finance Solutions, LLC. Sponsel joined ATEC in May 2018 as Area Vice President, West.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Every investor in Alphatec Holdings, Inc. (NASDAQ:ATEC) should be aware of the most powerful shareholder groups. General...
Alphatec Holdings Inc is a medical technology company. Warning! GuruFocus has detected 1 Warning Sign with ATEC. For the last quarter Alphatec Holdings Inc reported a revenue of $25.3 million, compared with the revenue of $26.28 million during the same period a year ago.
It marks the first of six IdentiTi implant systems the Company expects to commercially introduce in 2019. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.
ATEC will present at the Cowen 39th Annual Healthcare conference, located at the Boston Marriott Copley Place in Boston. The Company’s live presentation is scheduled for Monday, March 11 at 11:20 a.m. A copy of the presentation will be available online from the investor relations page of the Company's corporate website at www.atecspine.com.
CARLSBAD, Calif., March 07, 2019 -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results and operating highlights for the fourth.
NEW YORK, NY / ACCESSWIRE / March 7, 2019 / Alphatec Holdings, Inc. (NASDAQ: ATEC ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 7, 2019 at 4:30 PM ...
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC) announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its automated SafeOp neuromonitoring system for use in real-time intraoperative nerve location and health assessment. “I could not be more excited to integrate this revolutionary technology into our growing number of spine approaches,” said Pat Miles, Chairman and Chief Executive Officer. The next-generation technology of the SafeOp system represents a significant advancement in two intraoperative neurophysiological monitoring (IONM) modalities: somatosensory evoked potential (SSEP), and electromyography (EMG). SSEP assesses the functional health of the spinal cord and nerves, while EMG enables surgeons to test nerves for their location, proximity, and conduction. The SafeOp automated SSEP technology has been successfully used in more than 1,000 surgeries to identify potential nerve injury from patient positioning, and has demonstrated reliability in monitoring peripheral nerves in spine surgery.
CARLSBAD, Calif., Feb. 21, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”) announced today that the Company plans to release its fourth quarter and.
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (ATEC) today announced several favorable developments in its ongoing patent litigation with NuVasive, Inc. (NUVA). “We are extremely pleased with the many legal successes that we have seen to date in this lawsuit, including the Court’s entry of the stay,” said Pat Miles, ATEC’s Chairman and Chief Executive Officer.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Alphatec Holdings, Read More...
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (ATEC) today announced preliminary revenue results for the fourth quarter and full year ended December 31, 2018 and provided revenue guidance for the full year 2019. The Company also announced that Terry Rich has resigned as President, Chief Operating Officer, and as a member of the ATEC Board of Directors. Jeff Rydin, a member of the ATEC Board, will assume interim leadership of the Company’s sales organization, while Chief Executive Officer Pat Miles will assume Rich’s operations responsibilities in a combined role as President and CEO.
Alphatec Holdings (ATEC) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Alphatec (ATEC) delivered earnings and revenue surprises of -69.23% and -3.84%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Carlsbad, California-based company said it had a loss of 22 cents per share. The medical equipment and supplies holding company posted revenue of $23 million in the period. Alphatec expects full-year ...
CARLSBAD, Calif., Nov. 08, 2018 -- Alphatec Holdings, Inc. (“ATEC,” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve.
Alphatec Holdings Inc’s (NASDAQ:ATEC): Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. The US$129m market-cap Read More...
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced it will present at the Stifel 2018 Healthcare Conference on November 14, 2018, at 2:00 P.M. EST at the Lotte New York Palace Hotel. A copy of the presentation will be available online from the investor relations page of the Company's corporate website at www.atecspine.com. Alphatec Holdings, Inc., through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma.